Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling

J H M van Delft1, E van Agen, S G J van Breda

  • 1Department of Health Risk Analysis and Toxicology, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands. j.vandelft@grat.unimaas.nl

Carcinogenesis
|February 14, 2004
PubMed

Insights

Gene expression profiling can distinguish between genotoxic (DNA-damaging) and non-genotoxic (non-DNA-damaging) carcinogens. This method shows promise for classifying chemical carcinogens based on their distinct mechanisms of action.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Genetics

Background:

  • Chemical carcinogenesis involves two main mechanisms: genotoxic (DNA-damaging) and non-genotoxic (non-DNA-damaging).
  • These distinct mechanisms are hypothesized to result in different gene expression patterns.

Purpose of the Study:

  • To investigate if gene expression profiling can classify chemical carcinogens as genotoxic or non-genotoxic.
  • To assess the applicability of expression profiling for distinguishing between different modes of carcinogenic action.

Main Methods:

  • Analysis of gene expression profiles in HepG2 cells treated with 20 chemical carcinogens using cDNA microarrays.
  • Development and testing of classification models based on Pearson correlation of the 20 most discriminating genes.
  • Data analysis included training and validation sets, with iterative refinement by excluding marginal effects.

Main Results:

  • Initial classification accuracy was 81% for the training set and 33% for the validation set.
  • Excluding treatments with marginal effects improved discrimination to 92% (training) and 100% (validation).
  • Further exclusion of minimally altered gene expression signals yielded 94% (training) and 80% (validation) accuracy.

Conclusions:

  • Gene expression profiling effectively discriminates between genotoxic and non-genotoxic carcinogens.
  • This approach demonstrates the principle of classifying carcinogens based on their distinct molecular mechanisms.
  • Expression profiling is a viable tool for understanding and categorizing chemical carcinogen actions.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
In-vitro Mutagenesis (Gene Knockouts)02:29

In-vitro Mutagenesis (Gene Knockouts)

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...